Evaluation of Tamsulosin in the Treatment of Ureteral Stones

PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
UreterolithiasisUreteral Calculi
Interventions
DRUG

Tamsulosin

Oral tamsulosin once a day until stone elimination or the end of the follow-up (42 days)

DRUG

Placebo

Oral placebo of tamsulosin once a day until stone elimination or the end of the follow-up (42 days)

Trial Locations (6)

35033

Service d'Urologie- Hôpital Pontchaillou, Rennes

35600

Hôpital de Redon, Redon

37044

Service d'Urologie - Hôpital Bretonneau, Tours

51092

Service d'Urologie- Hôpital Robert Debré, Reims

75005

Service d'Urologie- Hôpital du Val de Grâce, Paris

86021

Service d'Urologie - Hôpital de La Milétrie, Poitiers

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Yamanouchi

UNKNOWN

lead

Rennes University Hospital

OTHER

NCT00151567 - Evaluation of Tamsulosin in the Treatment of Ureteral Stones | Biotech Hunter | Biotech Hunter